Justification of 150 mg clopidogrel in patients with high on‐clopidogrel platelet reactivity

Abstract

One-month administration of 150 mg maintenance dose of clopidogrel reduces platelet reactivity and might decrease the risk of thrombo-ischaemic complications in stable angina patients with HPR identified by LTA.